Private Wealth Management Group’s InMed Pharmaceuticals INM Stock Holding History

Private Wealth Management Group’s Portfolio INM Stock Details INM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.75K	Hold	5,000	–	–	﹤0.01%	658
2026 Q1	$3.23K	Buy	+5,000	New	+$4.71K	﹤0.01%	920

Other funds holding INM

BCV

Banque Cantonale Vaudoise Lausanne, Switzerland $722M AUM 30.45% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Private Wealth Management Group's INM Position: Q2 2026 in Review

Private Wealth Management Group held its InMed Pharmaceuticals (INM) position steady in Q2 2026 at 5,000 shares worth $7.75K. The position accounts for ﹤0.01% of the portfolio, ranked #658.

Private Wealth Management Group first reported a position in INM in Q1 2026 and has held it in 2 quarters since. 3 funds tracked by Wall St. Rank hold INM as of Q2 2026.

Private Wealth Management Group held 5,000 shares of InMed Pharmaceuticals worth $7.75K as of Q2 2026.
Private Wealth Management Group left its InMed Pharmaceuticals share count unchanged in Q2 2026.
InMed Pharmaceuticals made up ﹤0.01% of Private Wealth Management Group's portfolio in Q2 2026, its #658 holding.
Private Wealth Management Group first reported a position in InMed Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
3 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.